These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37465907)

  • 1. N acetylcysteine in the treatment of alcohol use disorder: a randomized, double-blind, placebo-controlled trial.
    Morley KC; Peruch S; Adams C; Towers E; Tremonti C; Watt J; Jamshidi N; Haber PS
    Alcohol Alcohol; 2023 Sep; 58(5):553-560. PubMed ID: 37465907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial.
    Squeglia LM; Tomko RL; Baker NL; McClure EA; Book GA; Gray KM
    Drug Alcohol Depend; 2018 Apr; 185():17-22. PubMed ID: 29413434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.
    Bogenschutz MP; Ross S; Bhatt S; Baron T; Forcehimes AA; Laska E; Mennenga SE; O'Donnell K; Owens LT; Podrebarac S; Rotrosen J; Tonigan JS; Worth L
    JAMA Psychiatry; 2022 Oct; 79(10):953-962. PubMed ID: 36001306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial.
    Anton RF; Latham P; Voronin K; Book S; Hoffman M; Prisciandaro J; Bristol E
    JAMA Intern Med; 2020 May; 180(5):728-736. PubMed ID: 32150232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial.
    Back SE; Gray K; Santa Ana E; Jones JL; Jarnecke AM; Joseph JE; Prisciandaro J; Killeen T; Brown DG; Taimina L; Compean E; Malcolm R; Flanagan JC; Kalivas PW
    Contemp Clin Trials; 2020 Apr; 91():105961. PubMed ID: 32087337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and Safety.
    Falk DE; Ryan ML; Fertig JB; Devine EG; Cruz R; Brown ES; Burns H; Salloum IM; Newport DJ; Mendelson J; Galloway G; Kampman K; Brooks C; Green AI; Brunette MF; Rosenthal RN; Dunn KE; Strain EC; Ray L; Shoptaw S; Ait-Daoud Tiouririne N; Gunderson EW; Ransom J; Scott C; Leggio L; Caras S; Mason BJ; Litten RZ;
    Alcohol Clin Exp Res; 2019 Jan; 43(1):158-169. PubMed ID: 30403402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
    McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
    Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baclofen for alcohol use disorder.
    Agabio R; Saulle R; Rösner S; Minozzi S
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012557. PubMed ID: 36637087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerability of topiramate and N-acetyl cysteine combination in individuals with alcohol use disorder: a 12 week, randomized, double-blind, pilot study.
    Tiouririne NA; Kalelioglu T; Seneviratne C; Wang XQ
    Alcohol Alcohol; 2024 Jan; 59(2):. PubMed ID: 38069498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial.
    Burnette EM; Baskerville WA; Grodin EN; Ray LA
    Trials; 2020 Sep; 21(1):779. PubMed ID: 32912290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol use disorder severity moderates clinical response to varenicline.
    Donato S; Green R; Ray LA
    Alcohol Clin Exp Res; 2021 Sep; 45(9):1877-1887. PubMed ID: 34486130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mecamylamine treatment for alcohol dependence: a randomized controlled trial.
    Petrakis IL; Ralevski E; Gueorguieva R; O'Malley SS; Arias A; Sevarino KA; Jane JS; O'Brien E; Krystal JH
    Addiction; 2018 Jan; 113(1):6-14. PubMed ID: 28710873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot double-blind treatment trial of memantine for alcohol dependence.
    Evans SM; Levin FR; Brooks DJ; Garawi F
    Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baclofen for alcohol use disorder.
    Minozzi S; Saulle R; Rösner S
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012557. PubMed ID: 30484285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol.
    Maier A; Dharan A; Oliver G; Berk M; Redston S; Back SE; Kalivas P; Ng C; Kanaan RA
    BMC Psychiatry; 2020 Aug; 20(1):397. PubMed ID: 32762663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderation of Prazosin's Efficacy by Alcohol Withdrawal Symptoms.
    Sinha R; Wemm S; Fogelman N; Milivojevic V; Morgan PM; Angarita GA; Hermes G; Fox HC
    Am J Psychiatry; 2021 May; 178(5):447-458. PubMed ID: 33207935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A double blind placebo controlled randomized clinical trial of the efficacy and safety of pregabalin in induction of remission in patients with alcohol dependence].
    Krupitsky EM; Rybakova KV; Skurat EP; Semenova NV; Neznanov NG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(1):33-43. PubMed ID: 32105267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation.
    Squeglia LM; Baker NL; McClure EA; Tomko RL; Adisetiyo V; Gray KM
    Addict Behav; 2016 Dec; 63():172-7. PubMed ID: 27521979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate for treating alcohol dependence: a randomized controlled trial.
    Johnson BA; Rosenthal N; Capece JA; Wiegand F; Mao L; Beyers K; McKay A; Ait-Daoud N; Anton RF; Ciraulo DA; Kranzler HR; Mann K; O'Malley SS; Swift RM; ;
    JAMA; 2007 Oct; 298(14):1641-51. PubMed ID: 17925516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.